HOME › DRUGS › LINVOSELTAMAB
ACTIVE SUBSTANCE / INN

LINVOSELTAMAB

Brand name(s): Lynozyfic
EMA LISTED
AUTHORISED
Multiple Myeloma
ACTIVE SUBSTANCE
Linvoseltamab
REGULATORS
EMA
SPONSORS / MAH
Regeneron Ireland Designated Activity Company (DAC)
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LynozyficRegeneron Ireland Designated Activity Company (DAC)Authorised23/04/2025Multiple Myeloma

FULL INTELLIGENCE ON LINVOSELTAMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →